Danimer Scientific Inc

Danimer Scientific — Q2 2022 Earnings Presentation

13 slides from Danimer Scientific's earnings presentation, Aug 9, 2022

  1. Slide 1: Second Quarter 2022 Earnings Presentation

    Second Quarter 2022 Earnings Presentation August 9, 2022

  2. Slide 2: Disclaimer

    Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitatio

  3. Slide 3: Danimer's Strategic Priorities

    Danimer’s Strategic Priorities Expand Capacity to Achieve Scale 1 2 3 4 5 6 Lead with Innovation to Address a Broad Range of Customer Needs Grow Customer Partnerships and Product Volume Commitments Secure Cost-Effective Inputs Attain Favorable Unit Economics to Enhance Margins Enhance Team Capabilit

  4. Slide 4: Recent Business Highlights

    Recent Business Highlights Business Highlights Continued execution of growth strategy to transform the bioplastics market PHA revenues up ~85% YoY, now representing 61% of total revenues Expanded partnership with Kemira to commercialize biodegradable aqueous coatings Plackers announced compostable d

  5. Slide 5: Customer Partnerships & Business Development Initiatives

    Customer Partnerships & Business Development Initiatives Exclusive license and supply agreement to commercialize PHA based aqueous coatings to be used on paper-based food & beverage applications Expected to be immediately cash flow positive upon launch with no significant capex Business Development

  6. Slide 6: Expand Capacity: Kentucky Facility Update

    Expand Capacity: Kentucky Facility Update – Phase II Started Commissioning in June Kentucky Facility Expansion Update: Facility capacity expanded to ~65mm lbs. of Nodax-based finished product, annually(1) Phase I (Completed 2020): ~20mm lbs. annually(1) Phase II (Started Commissioning in Q2 2022): ~

  7. Slide 7: Expand Capacity: Bainbridge Greenfield Facility Update

    Expand Capacity: Bainbridge Greenfield Facility Update Facility Build Out Timeline Greenfield Facility Overview Commentary Location of Greenfield site selected in Georgia due to better utilities rates and incentives Some equipment has been pre-ordered to avoid higher prices, but inflation remains a

  8. Slide 8: Q2 2022 Financial Summary

    Q2 2022 Financial Summary PHA-based revenues increased by ~85% YoY, representing 61% of revenue vs 29% in Q2 2021 Gross profit down YoY due lower R&D gross profit and shift in product mix Prior increases in headcount in R&D and SG&A YoY to support expansion plans Key Messages Financial Summary Note:

  9. Slide 9: Financial Outlook

    Financial Outlook 4% PHA PHA Gross Margin Total Gross Margin SG&A & R&D as % of Sales Danimer Catalytic Technologies Profit Contribution Adjusted EBITDA 2022E Adj. EBITDA of ($45) - ($35) Million Expect 2022E Capex of $175 to $185 million(1) and year end cash balance in excess of $60 million Change

  10. Slide 10: Forward Catalysts

    Forward Catalysts Continued focus on driving operational costs down as we scale production Large and growing TAM Believed to be the only PHA product offering at commercial scale production Increasing governmental regulations on single-plastic uses Demand from blue chip multinational customers Buildi

  11. Slide 11: Appendix

    4 danimer ~ scientific Appendix Per nin yy -

  12. Slide 12: EBITDA and EBITDAR Reconciliation

    EBITDA and EBITDAR Reconciliation Note: Totals may not foot due to rounding.

  13. Slide 13: Adjusted Gross Profit Reconciliation

    Adjusted Gross Profit Reconciliation Note: Totals may not foot due to rounding.

Danimer Scientific — Q2 2022 Earnings Presentation on 6ix